5q- Syndrome

Search Trials
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Status:
Completed
Last Changed:
Apr 25, 2019
First Changed:
Sep 13, 2010
Disease(s):
Hematopoietic/Lymphoid Cancer
Intervention(s):
infection prophylaxis and managementlaboratory biomarker analysisflow cytometryDNA analysisRNA analysismanagement of therapy complicationsganciclovirvalganciclovirfoscarnet sodiumantiviral therapypolymerase chain reactionprotein expression analysis
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
Status:
Active, not recruiting
Last Changed:
Nov 19, 2018
First Changed:
Apr 30, 2012
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
tetanus-CMV fusion peptide vaccinelaboratory biomarker analysis
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
Status:
Completed
Last Changed:
Mar 17, 2014
First Changed:
Apr 30, 2009
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
sunitinib malatepharmacological studylaboratory biomarker analysis
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Status:
Completed
Last Changed:
May 24, 2017
First Changed:
Jun 3, 2005
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatetotal-body irradiationperipheral blood stem cell transplantationcyclosporinemycophenolate mofetillaboratory biomarker analysis
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Active, not recruiting
Last Changed:
Mar 26, 2019
First Changed:
Feb 9, 2012
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatemelphalantotal-body irradiationtacrolimusmycophenolate mofetilmethotrexatelaboratory biomarker analysisallogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantation

Connect. Empower. Inspire.